Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Canfor Q3 Net Loss Narrows

Canfor Q3 Net Loss Narrows

MT newswireMT newswire2026/11/04 12:13
08:13 AM EST, 11/04/2026 (MT Newswires) -- Canfor (CFP.TO) reported third quarter net loss per share of CA$0.75 on Wednesday, compared with CA$1.48, a year earlier. Analysts polled by FactSet expected loss per share of CA$0.18. Sales increased to CA$1.28 billion in the three months ended Sept. 30, 2026, compared with CA$1.26 billion, a year-ago. Analysts expected CA$1.42 billion. "Looking ahead, we anticipate market conditions will remain challenging through the balance of the year, with softer seasonal demand for lumber and continued pressure in global pulp markets," said Canfor Chief Executive Officer Susan Yurkovich. Shares of the company closed up 1.97% to CA$14.98 on Tuesday on the Toronto Stock Exchange.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Dental treatment company vVardis has announced the terms for its $214 million US IPO.

智通财经•2026/11/09 06:41
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss

Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.

智通财经•2026/11/09 06:41
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss